#Petah Tikva #Denmark #Isotopia #Isoprotrace #Cardirad

Launch of Isoprotrace® in Sweden and Denmark

Isotopia Molecular Imaging, in collaboration with Cardirad, has officially launched Isoprotrace®, a cutting-edge Gallium-68 Gozetotide preparation kit for the imaging of prostate cancer, in Sweden and Denmark. This introduction marks a pivotal move toward enhancing accessibility to advanced diagnostic solutions in the Nordic countries, where precision in cancer detection is critically needed.

The Isoprotrace® kit is designed as a ready-to-use, multi-dose solution, facilitating healthcare professionals in the efficient preparation of Gallium-68 Gozetotide for intravenous administration. This capability is especially beneficial for the primary staging of high-risk prostate cancer patients prior to curative treatments and for those suspected of disease recurrence, indicated by elevated PSA levels. By enhancing the accuracy of prostate cancer detection, Isoprotrace® represents an essential tool for improving patient management and outcomes.

John Storbjörk, President of Cardirad, spoke about the significance of this partnership, stating, "We are excited to be collaborating with Isotopia to deliver this revolutionary diagnostic tool to clinicians and patients across the Nordic region. The launch of Isoprotrace® will not only support improved diagnostic accuracy but will also facilitate a better trajectory for patient care in prostate cancer."

Tzachi Levy, General Manager of Isotopia's aseptic plant, also expressed his enthusiasm, remarking, "The launch of Isoprotrace® in Sweden and Denmark highlights our dedication to advancing prostate cancer treatment globally. Through our partnership with Cardirad, we are ensuring patients and clinicians in the Nordics can access cutting-edge diagnostic technology."

Isoprotrace® has already gained marketing authorization and is available in various countries, including the Netherlands, UK, and Germany, with plans for expansion to more EU countries. This rollout not only exemplifies Isotopia's robust supply chain but also underscores its commitment to making innovative radiopharmaceuticals accessible to patients in need.

For those seeking more information about Isoprotrace®, including details on product availability in Sweden and Denmark, healthcare providers can reach out to Cardirad directly at email protected] or visit Isotopia’s official product page at [Isotopia Global.

About Isotopia Molecular Imaging

Isotopia Molecular Imaging is a trailblazer in the field of radiopharmaceutical development, specifically focusing on theranostic solutions that enhance both diagnostic accuracy and treatment efficacy. The company holds a steadfast commitment to innovation and a patient-centered approach, ensuring that reliable, high-quality radiopharmaceuticals are delivered to healthcare providers around the globe.

About Cardirad Nordic

Cardirad Nordic specializes in distributing advanced healthcare products throughout the Nordic and Baltic regions. The company is dedicated to providing healthcare providers with access to leading medical technologies to facilitate superior patient care.

With the launch of Isoprotrace®, both Isotopia and Cardirad take a significant step in the realm of cancer care, embodying their mission to leverage technology advancements for better health outcomes for patients battling prostate cancer.